Bliss GVS Pharma Limited
NSE: BLISSGVS | Information Technology
Market Fundamentals
Stock Intelligence & News
Bliss GVS Pharma Limited
Bliss GVS Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 03, 2026. |SUBJECT: Outcome of Board Meeting
Read Full Analysis →Bliss GVS Pharma Limited
Bliss GVS Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Bliss GVS Pharma Limited
Bliss GVS Pharma Limited has informed the Exchange regarding 'the communication sent to shareholders regarding Intimation of Tax Deduction on Dividend.'. |SUBJECT: Updates
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Bliss GVS Pharma Limited
Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication 41st Annual General Meeting of the Company |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Anupam Rasayan India Limited
Anupam Rasayan India Limited has informed the Exchange about Draft Letter of Offer filed by the Manager to the Offer with SEBI yesterday, relating to the mandatory open offer by our Company to the public shareholders of Bliss GVS Pharma Limited |SUBJECT: General Updates
Read Full Analysis →Bliss GVS Pharma Limited
Bliss GVS Pharma Limited has informed the Exchange about Submission Of Draft Letter Of Offer In Relation To The Open Offer Made To The Public Shareholders Of Bliss GVS Pharma Limited Under The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 |SUBJECT: General Updates
Read Full Analysis →Bliss GVS Pharma Limited
SBI Capital Markets Limited has Submitted to the Exchange a copy of newspaper publication regarding the Detailed Public Statement in connection with the Open Offer made to the public shareholders of the Company. |SUBJECT: Public Announcement-Open Offer
Read Full Analysis →Bliss GVS Pharma Limited
SBI Capital Markets Limited (Manager to the Open Offer) has submitted to the Exchange a copy of Detailed Public Statement in terms of Regulation 3(1) and Regulation 4 read with Regulation 13(4), Regulation 15(2) and other applicable Regulations of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, to the Public Shareholders of Bliss GVS Pharma Limited (Target Company). |SUBJECT: Public Announcement-Open Offer
Read Full Analysis →Anupam Rasayan India Limited
Anupam Rasayan India Limited has informed the Exchange about Copy of Newspaper Publication published pertaining to the Detailed Public Statement for the Open Offer to public shareholders of Bliss GVS Pharma Limited |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Bliss GVS Pharma Limited
BLISS GVS PHARMA LIMITED has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
Read Full Analysis →Get instant alerts when BLISSGVS breaks news
Join investors who track Bliss GVS Pharma Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for BLISSGVS?
BLISSGVS is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Bliss GVS Pharma Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding BLISSGVS to your custom watchlist.